Twist Bioscience Corp
TWST- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001581280
In the last 90 days, Twist Bioscience Corp insiders filed 0 open-market purchases and 30 sales; 337 institutions reported holding it in 13F filings for Q2 2026, worth $7.85B in total; ARK Invest is the only superinvestor holding it.
13F holders, Q1 2026
Institutional positions in Twist Bioscience Corp as of Mar 31, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 281
- +43 vs. Q4 2025
- Shares held
- 77.0M
- +7.86M (+11.4%) vs. Q4 2025
- Total value
- $3.66B
- +$1.46B (+66.8%) vs. Q4 2025
- New holders
- 70
- 76 more added
- Sold out
- 27
- 89 more reduced
6 institutions that held it in Q4 2025 haven't filed for Q1 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TWST on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 337 | $7.85B |
| Q1 2026 | 281 | $3.66B |
| Q4 2025 | 244 | $2.38B |
| Q3 2025 | 239 | $2.08B |
| Q2 2025 | 244 | $2.62B |
| Q1 2025 | 263 | $2.73B |
| Q4 2024 | 247 | $3.08B |
| Q3 2024 | 246 | $2.99B |
| Q2 2024 | 263 | $3.25B |
| Q1 2024 | 238 | $2.30B |
| Q4 2023 | 219 | $2.46B |
| Q3 2023 | 196 | $1.34B |
| Q2 2023 | 194 | $1.39B |
| Q1 2023 | 203 | $956.8M |
| Q4 2022 | 199 | $1.45B |
| Q3 2022 | 221 | $2.04B |
| Q2 2022 | 205 | $2.01B |
| Q1 2022 | 213 | $2.92B |
| Q4 2021 | 237 | $3.96B |
| Q3 2021 | 238 | $5.20B |
| Q2 2021 | 245 | $6.40B |
| Q1 2021 | 240 | $5.82B |
Institutions, Q1 2026
Shares, value and share of portfolio for each institution holding Twist Bioscience Corp; share changes are against Q4 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Amalgamated Bank | 0 | $0 | 0.00% | −1,880−100.0% | Sold out |
| Daiwa Securities Group Inc. | 0 | $0 | 0.00% | −210−100.0% | Sold out |
| Louisbourg Investments Inc. | 0 | $0 | 0.00% | −95−100.0% | Sold out |
| Golden State Wealth Management, LLC | 0 | $0 | 0.00% | −76−100.0% | Sold out |
| United Financial Planning Group LLC | 0 | $0 | 0.00% | −25−100.0% | Sold out |
| SageView Advisory Group, LLC | 0 | $0 | 0.00% | −14−100.0% | Sold out |
| Aster Capital Management (DIFC) Ltd | 0 | $0 | 0.00% | −1−100.0% | Sold out |
| Turning Point Benefit Group, Inc. | 0 | $0 | 0.00% | −1−100.0% | Sold out |
| Vanguard Group Inc | – | – | – | – | Not filed |
| Clarius Group, LLC | – | – | – | – | Not filed |
| CIBC Private Wealth Group, LLC | – | – | – | – | Not filed |
| Comerica Bank | – | – | – | – | Not filed |
| Global Retirement Partners, LLC | – | – | – | – | Not filed |
| ORG Partners LLC | – | – | – | – | Not filed |